Novo Nordisk leased the 9th floor in Tiriac Tower office building

Aurel Constantin 26/05/2020 | 11:48

CBRE, leader in the real estate consultancy market, advised the relocation process for the pharmaceutical company Novo Nordisk, who leased an area of 580 sq m offices in the Tiriac Tower building, located in Victoriei Square. The transaction was signed in March, in full swing of the  COVID-19 pandemic lockdown, thus confirming the continuity of the transactions in the real estate market.

„The construction of Tiriac Tower carries on uninterruptedly and we have recently completed the superstructure of the building, respecting the time and safety conditions agreed. Tiriac Tower will be the most stylish and safe building in the central area of the Capital city, being also the only building in the Victoriei Square area that offers 1,200 sqm of terraces and patios, a benefit for which companies have shown high interest in the last two months”, revealed Razvan Enache, Managing Director of Țiriac Imobiliare.

The Danish company Novo Nordisk, worldwide known for its insulin production, will take up the 9th floor of the Tiriac Tower building, consisting of about 580 sq m of offices and two terraces with an area of over 120 sq m, according to CBRE, who advised the transaction together with Victor Rachită.

“We wanted a modern building, with efficient spaces for our current needs, which reflects the sustainable approach of Novo Nordisk. Furthermore, we wished to remain in the central business area of the city, keeping everything at the fingertips of our employees and partners. Tiriac Tower met all these criteria and additionally offered a space flooded with natural daylight and large outdoor terraces, which are also important aspects for our team”, explained Cecilia Radu, General Manager of Novo Nordisk.

Tiriac Tower is the newest building in Victoriei Square, the iconic business area of the Capital city. The building has a leasable area of approximately 16,500 sq m, comprising 12 floors and will accommodate occupiers in the fields of law, strategic consulting, insurance, engineering and the pharmaceutical industry. CBRE has advised the lease of a total volume of 30 percent of the entire building so far.

“The show must go on is the anthem of every strong business these days and the transaction between Novo Nordisk and Tiriac Tower is yet another proof. During 2020-2021, approximately 300,000 sq m of office space will reach the expiration of lease contracts and we expect to see a similar proportion of renegotiations and relocation deals. We are also discussing with companies that have announced their intention to expand even during the lockdown period, relying on further business growth”, concluded Razvan Iorgu.

In addition to the 16,500 square meters of offices, Tiriac Tower includes 259 underground parking spaces laid out in 5 basements, including parking lots for electric cars, as well as 42 spaces for bicycles. The project achieved “Core and Shell” LEED (Leadership in Energy and Environmental Design) pre-certification, for high standards of construction quality, sustainability and energy efficiency. The architecture of the building includes interior spaces designed to take full advantage of the natural light throughout the day.

The future occupiers will enjoy the utmost flexibility for arrangements, having the possibility to occupy spaces that vary between 500 and 2,000 sqm for each floor. In terms of interior design, the quality of materials and the elegance of the decorative lines will define the excellent environment offered to those who choose to set up their offices in this location.

BR Magazine | Latest Issue

Download PDF: Business Review Magazine March (II) 2024 Issue

The March (II) 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “BAT DBS Romania Hub: A Vibrant New Office For An Employee-Centric
Aurel Constantin | 27/03/2024 | 17:32
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue